Influenza vaccine: recommendations of the Public Health Service Advisory Committee on Immunization Practices, Center for Disease Control, U.S. Department of Health, Education, and Welfare; Atlanta, Georgia.
The bivalent influenza vaccines for the 1977-1978 immunization period will contain inactivated influenza A and B viruses representing currently prevalent strains and will be available in "split-virus" and "whole-virus" preparations, which differ in side-effects and immunogenicity. Annual vaccination is recommended for adults and children of all ages with chronic diseases, especially diabetes mellitus or cardiac, pulmonary, or renal disease. Vaccination is also recommended for persons over age 65 years and persons in vital community services. Age-related doses are specified in a table, and side-effects and use in pregnancy are discussed in the text.
D005260:Female; D006801:Humans; D007252:Influenza Vaccines / Q000009:adverse effects / Q000032:analysis; D007251:Influenza, Human / Q000517:prevention & control; D011247:Pregnancy; D014611:Vaccination
D007252:Influenza Vaccines